Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome

8 Oct 2013

Abstract excerpt

BACKGROUND: Increased plasma levels of circulating cell-free DNA (c-f DNA) have been recently described in diseases related to ischemia and/or hypoxia. Preeclampsia (PCL) is a hypertensive disorder of pregnancy, of unknown origin, where a defective placentation resulting in placental ischemia plays an important role. HELLP syndrome (haemolysis, elevated liver enzymes, and low platelet count) is the most serious...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24103646
DOI: 10.1093/ajh/hpt187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP SyndromePMID 24103646Read ↗

Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome as a Complication of Preeclampsia in Pregnant Women Increases the Amount of Cell-free Fetal and Maternal DNA in Maternal Plasma and SerumSemantic proximity Read ↗

Cell-free fetal DNA and pregnancy-related complications (Review)Semantic proximity Read ↗

HELLP Syndrome—Holistic Insight into PathophysiologySemantic proximity Read ↗

Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications.Semantic proximity Read ↗

Evaluation of albumin-based inflammatory markers as diagnostic tools in HELLP syndromeSemantic proximity Read ↗

Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth RestrictionSemantic proximity Read ↗

Increased Maternal Plasma Fetal DNA Concentrations in Women Who Eventually Develop Preeclampsia.Semantic proximity Read ↗

Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic reviewSemantic proximity Read ↗

Total cell‐free DNA (β‐globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screeningSemantic proximity Read ↗

Circulatory Fetal and Maternal DNA in Pregnancies at Risk and Those Affected by PreeclampsiaSemantic proximity Read ↗

Preeclamptic patient-derived circulating cell-free DNA activates the production of inflammatory cytokines via toll-like receptor 9 signalling in the human placentaSemantic proximity Read ↗

Elevated cell‐free fetal DNA contributes to placental inflammation and antiangiogenesis via AIM2 and IFI16 during pre‐eclampsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.